Tilray Inc (NASDAQ:TLRY)

20.92
Delayed Data
As of 4:00pm ET
 +0.94 / +4.70%
Today’s Change
19.41
Today|||52-Week Range
120.40
-70.34%
Year-to-Date
3 Glaring Problems in Tilray's Q3 Results
Nov 13 / MotleyFool.com - Paid Partner Content
Despite Poor Financial Results, This Pot Stock May Be Worth a Second Look
Nov 12 / MotleyFool.com - Paid Partner Content
Tilray Inc (TLRY) Q3 2019 Earnings Call Transcript
Nov 13 / MotleyFool.com - Paid Partner Content
5 Marijuana Stocks to Watch This Week
Nov 11 / MotleyFool.com - Paid Partner Content
Tilray Sales Blast Higher in Mixed Q3
Nov 12 / MotleyFool.com - Paid Partner Content
3 Things to Watch in the Stock Market This Week
Nov 10 / MotleyFool.com - Paid Partner Content
3 Huge Questions Tilray Will Have to Answer With Its Third-Quarter Report
Nov 12 / MotleyFool.com - Paid Partner Content
It's Time to Buy Cannabis Stocks, Says 1 Wall Street Firm
Nov 08 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close19.98
Today’s open20.35
Day’s range20.23 - 21.26
Volume2,268,081
Average volume (3 months)1,668,048
Market cap$2.0B
Data as of 4:00pm ET, 11/20/2019

Growth & Valuation

Earnings growth (last year)-873.51%
Earnings growth (this year)-64.92%
Earnings growth (next 5 years)--
Revenue growth (last year)+110.00%
P/E ratioNM
Price/Sales135.76
Price/Book9.39

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...+0.18+0.80%
XNCRXencor Inc+0.76+2.01%
EIDXEidos Therapeutics I...-1.95-3.39%
XLRNAcceleron Pharma Inc+0.19+0.44%
Data as of 4:00pm ET, 11/20/2019

Financials

Next reporting dateMarch 23, 2020
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$43.1M
Annual profit (last year)-$67.7M
Net profit margin-157.02%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Nanaimo, British Columbia

Forecasts